Tuesday - July 14, 2026
Scleroderma Added to AMP AIM Research Project
July 13, 2026
DANVERS, Massachusetts, July 13 -- The National Scleroderma Foundation issued the following news:

* * *

Scleroderma Added to AMP AIM Research Project

*

The National Scleroderma Foundation is excited to announce that scleroderma will be part of the expanded Accelerated Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP(r) AIM) program.

The Foundation has partnered with the Foundation for the National Institutes of H . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products